Vaccine Improves Outcomes in Lynch Syndrome Model
July 29, 2021
Cancer Vaccine Improves Outcomes in Lynch Syndrome Model
A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital. The preclinical results could eventually lead to vaccines that cause the immune system to target cancers early in their development, preventing the disease from becoming established.
Trial Shows Cell Therapy May Prevent Infections in Patients
July 16, 2021
Treatment with a ready-made preparation of human immune cells helps prevent infections in people whose immune systems are temporarily weakened by leukemia treatment, according to a phase 2 clinical trial led by researchers at Weill Cornell Medicine and NewYork-Presbyterian. Infections are a significant problem in patients undergoing chemotherapy for cancer.
Summer 2021 EIPM External Newsletter
July 12, 2021
July 2021
Dear Friend of the Englander Institute for Precision Medicine,
What you’ll find in medicine cabinets in 2030
July 12, 2021
The modern medicine cabinet is filled with all sorts of things, from pain relievers and birth control pills to antibiotics and bandages.
New Research on How Tumors Evolve to Become Aggressive
July 8, 2021
Research Suggests How Tumors Evolve to Become Aggressive Form of Prostate Cancer
Single-cell RNA sequencing of prostate cells from mice with alterations in Pten, RB1 and MYCN identified 10 major cell subtypes and enabled researchers to study tumor heterogeneity with unprecedented resolution. Credit: Dr. Nicholas Brady.
New Jersey Woman Gets a Second Chance — Thanks to Precision Medicine
July 5, 2021
Cheryl Bonder had been living with a vaguely defined blood malignancy for years when her prognosis rapidly took a turn for the worse: her condition was progressing toward acute myelogenous leukemia (AML), an aggressive cancer of the blood and bone marrow. “I was going south pretty quickly without another good plan in place,” recalls Bonder, a 61 year old health and wellness coach from New Jersey. Traditional chemotherapy might have offered her a few more months, but that was not how she wanted her life to end.
Juneteenth and the Promise of Medical Equity
June 17, 2021
The enormous promise of precision medicine to advance science and speed new, highly targeted therapies to patients is exceeded only by its potential to achieve something even more important: To help bring equity to medicine.
EIPM: Combination Therapy Boosts Response, Cuts Treatment Time
June 15, 2021
Combining immunotherapy with targeted radiation resulted in a greater response rate than immunotherapy alone in a phase 2 clinical trial in patients with early-stage, non-small-cell lung cancer led by Weill Cornell Medicine and NewYork-Presbyterian investigators. In view of the safety and efficacy of the treatment, a larger trial is warranted.
Breast Cancer Risk in African Americans Tied to Genetic Variations
June 14, 2021
Two gene variants found in African American women may explain why they are more likely to be diagnosed with triple negative breast cancer (TNBC) than white women of European ancestry, according to Weill Cornell Medicine and NewYork-Presbyterian investigators. The study findings may have implications for developing better risk assessment tools for TNBC in African American women and for understanding why they have poorer TNBC outcomes.